ProjectBI 1402-0030 – Phase II Medikamentenstudie für Patienten mit einer post-traumatischen Belastungsstörung
Basic data
Acronym:
BI 1402-0030
Title:
Phase II Medikamentenstudie für Patienten mit einer post-traumatischen Belastungsstörung
Duration:
25/10/2022 to 31/08/2023
Abstract / short description:
Phase II Studie mit achtwöchiger medikamentöser Intervention, multicenter, randomisiert, doppeltblind, plazebo-kontrolliert, mit parallelen Gruppen mit dem Ziel, die Wirksamkeit und Sicherheit des Medikaments BI 1358894 bei Patientinnen und Patienten mit einer post-traumatischen Belastungsstörung zu untersuchen
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Other staff
Department of Psychology
Faculty of Science
Faculty of Science
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Ingelheim am Rhein, Rheinland-Pfalz, Germany